2016•Guoji zhongliuxue zazhiRequires access
Endocrine therapy for postmenopausal women with hormone receptor positive in advanced breast cancer
Xuexiang Huang
Open publisher page 0 citations
Abstract
With the emergence of new endocrine drugs and the development of research in resistance mechanisms, significant progress has been achieved in the endocrine treatment of breast cancer in recent years. Fulvestrant, the combination of endocrine drugs and the combination of targeted therapy with endocrine therapy will be effective treatments for postmenopausal women with hormone receptor positive in advanced breast cancer.
Key words:
Breast neoplasms; Receptors, estrogen; Therapy